COLUMBUS, Ohio–(BUSINESS WIRE)–Gnome Diagnostics, LLC (GnomeDX), a CLIA-certified personalized medicine company, announced the launch of its pharmacogenomic testing services – healthcare’s newest forefront of personalized medicine for patients. Adverse drug reactions are the 4th leading cause of death in the United States ahead of stroke, Alzheimer’s disease, and diabetes, and …